Sanofi recalls four batches of painkiller 'Combiflam' in India
Drug major Sanofi is recalling four batches of its painkiller Combiflam in India after the country's drugs regulator found the lots sub-standard. The company has taken the step after the Central Drugs Standard Control Organisation (CDSCO) found out that the batches of Combiflam were "not of standard quality" as they failed disintegretion tests. When contacted, a Sanofi India spokesperson told : "Some batches of Combiflam tablets were found to have a delayed disintegration time. There is a pharmaceutical parameter that requires the breakdown of a tablet in the human body to be assessed." In the case of Combiflam, though the disintegration time was delayed, doctors and patients can be assured that there is no impact on the safety and efficacy of the product, the spokesperson added.